로딩 중…
지수 로딩 중…
Lexeo Therapeutics, Inc. Common Stock
LXEO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$4.20+1.69%
2026-08-03
Financials
Valuation Metrics
Lexeo Therapeutics, Inc. Common Stock's Market Cap is $330M. At end of 2025 it was $606M. Ranked #2940 of 3,112 in US market (top 94%), #1313 of 1,445 on NASDAQ (top 91%), #240 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 89%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $330M | US#2,940/3,112 Sec#240/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-88M | US—/3,112 Sec—/269 |
| Total Assets | $250M | US#2,943/3,112 Sec#234/269 |
| Net Assets | $231M | US#2,679/3,112 Sec#184/269 |
| Value | ||
| P/B | 1.42x | US#744/3,112 Sec#36/269 |
| FCF Yield | -29.84% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -37.80% | US#2,678/3,112 Sec#146/269 |
| ROA | -34.95% | US#2,904/3,112 Sec#176/269 |
| Financial Health | ||
| Debt Ratio | 8.15% | US#83/3,112 Sec#38/269 |
| Total Debt | $7M | US#2,813/3,112 Sec#210/269 |
| FCF | $-98M | US#2,585/3,112 Sec#151/269 |
| Cash | $72M | US#2,399/3,112 Sec#200/269 |
| Current Ratio | 14.16x | US#168/3,112 Sec#54/269 |
| Performance | ||
| 1Y Return | -8.89% | US#2,404/3,112 Sec#213/269 |
| 1M Return | -10.45% | US#2,619/3,112 Sec#167/269 |
| From 52W High | -61.78% | US#2,949/3,112 Sec#243/269 |
| 1Y MDD | -61.15% | US#2,753/3,112 Sec#216/269 |
| Trading | ||
| Volume | 656,910 shares | US#1,853/3,112 Sec#182/269 |
| Trading Value | $3M | US#2,847/3,112 Sec#239/269 |
| Per Share | ||
| EPS | $-1.30 | US—/3,112 Sec—/269 |
| BPS | $1.98 | US#2,510/3,112 Sec#178/269 |